faeth (FTH)
20.57
-0.22 (1.06%)
Upcoming Events
Latest Headlines
Faeth Therapeutics (FTH) Reiterated at Market Outperform by Citizens After KOL Discussion
October 21, 2026 5:51 AM - StreetInsider
Faeth to present PIKTOR preclinical data at ESMO 2026
October 19, 2026 7:30 AM - StreetInsider
Faeth to Present Preclinical Data on PIKTOR in HR+/HER2- Breast Cancer Models at ESMO 2026
October 19, 2026 7:30 AM - BizWire
U.S. biotech SMids: Q3 earnings preview
October 18, 2026 8:00 PM - StreetInsider
William Blair Starts Faeth Therapeutics (FTH) at Outperform
October 16, 2026 3:13 AM - StreetInsider
Faeth Therapeutics (FTH) Reiterated at Market Outperform by Citizens Ahead of Topline Data from Ph2 Study
October 8, 2026 4:16 AM - StreetInsider
Faeth Therapeutics (FTH) Reiterated at Overweight by Cantor Fitzgerald After Investor Day
October 7, 2026 6:50 AM - StreetInsider
Faeth Therapeutics (FTH) Reiterated at Market Outperform by Citizens Before First Virtual KOL Event
October 7, 2026 4:27 AM - StreetInsider
Form 8-K Faeth Therapeutics, Inc. For: Sep 11
September 17, 2026 4:15 PM - SEC Filing
Faeth Therapeutics adds cancer biologist Karen Vousden to its board
September 17, 2026 4:00 PM - StreetInsider
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
September 17, 2026 4:00 PM - BizWire
Form 4 Faeth Therapeutics, Inc. For: Sep 11 Filed by: Vousden Karen H
September 15, 2026 4:59 PM - SEC Filing
Form 3 Faeth Therapeutics, Inc. For: Sep 11 Filed by: Vousden Karen H
September 15, 2026 4:57 PM - SEC Filing
Guggenheim Starts Faeth Therapeutics (FTH) at Buy, PT $70
September 15, 2026 4:14 PM - StreetInsider
Lucid Capital Markets Starts Faeth Therapeutics (FTH) at Buy
September 14, 2026 6:35 AM - StreetInsider
TD Cowen Starts Faeth Therapeutics (FTH) at Buy
September 9, 2026 5:44 AM - StreetInsider
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 28, 2026 7:30 AM - BizWire
Needham Starts Faeth Therapeutics (FTH) at Buy
August 21, 2026 5:48 AM - StreetInsider
FDA grants fast track status to Faeth's PIKTOR combo for endometrial cancer
August 17, 2026 7:31 AM - StreetInsider
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer
August 17, 2026 7:30 AM - BizWire
Form SCHEDULE 13G/A Faeth Therapeutics, Inc. Filed by: Caligan Partners LP
August 14, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A Faeth Therapeutics, Inc. Filed by: Trails Edge Capital Partners, LP
August 14, 2026 4:23 PM - SEC Filing
Form SCHEDULE 13G Faeth Therapeutics, Inc. Filed by: Khosla Ventures VI, L.P.
August 14, 2026 4:21 PM - SEC Filing
Form SCHEDULE 13G/A Faeth Therapeutics, Inc. Filed by: STEMPOINT CAPITAL LP
August 14, 2026 12:01 PM - SEC Filing
Faeth Therapeutics names two SVPs ahead of clinical milestones
August 14, 2026 7:31 AM - StreetInsider
Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments
August 14, 2026 7:30 AM - BizWire
Form 144 Faeth Therapeutics, Inc. Filed by: Cambrian BioPharma Inc
August 11, 2026 12:52 PM - SEC Filing
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 4:00 PM - BizWire
Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference
August 7, 2026 7:30 AM - BizWire
Faeth Therapeutics, Inc. (FTH) Tops Q2 EPS by 132c
August 4, 2026 8:22 AM - StreetInsider
Jones Trading Starts Faeth Therapeutics (FTH) at Buy
August 4, 2026 8:03 AM - StreetInsider
Form 10-Q Faeth Therapeutics, Inc. For: Jun 30
August 4, 2026 7:41 AM - SEC Filing
Form 8-K Faeth Therapeutics, Inc. For: Aug 04
August 4, 2026 7:41 AM - SEC Filing
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates
August 4, 2026 7:30 AM - BizWire
Raymond James Starts Faeth Therapeutics (FTH) at Outperform
July 31, 2026 6:05 AM - StreetInsider
Form 3 Faeth Therapeutics, Inc. For: Jun 15 Filed by: Khosla Ventures Seed Associates D, LLC
July 28, 2026 4:15 PM - SEC Filing
Oppenheimer Starts Faeth Therapeutics (FTH) at Outperform
July 27, 2026 4:31 PM - StreetInsider
Form 8-K Faeth Therapeutics, Inc. For: Jul 21
July 23, 2026 5:16 PM - SEC Filing
Form 4 Faeth Therapeutics, Inc. For: Jul 21 Filed by: Parikh Anand Kiran
July 23, 2026 4:15 PM - SEC Filing
Form 4 Faeth Therapeutics, Inc. For: Jul 21 Filed by: Craver Josiah
July 23, 2026 4:15 PM - SEC Filing
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 23, 2026 4:00 PM - BizWire
Full Article List
